Biomarkers |https://gbnegrinicv.netlify.app/tags/biomarkers/BiomarkersHugoBlox Kit (https://hugoblox.com)en-usSat, 30 May 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/media/icon.svgBiomarkershttps://gbnegrinicv.netlify.app/tags/biomarkers/Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant studyhttps://gbnegrinicv.netlify.app/publications/povala-head-lancet-2026/Sat, 30 May 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/povala-head-lancet-2026/Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trialshttps://gbnegrinicv.netlify.app/publications/ferreira-evaluating-2026/Tue, 13 Jan 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/ferreira-evaluating-2026/Low-dose CT for MRI-free quantification of tau PET in Alzheimer's disease: a multicentre, cross-sectional, comparison studyhttps://gbnegrinicv.netlify.app/publications/povala-ct-lanmit-2026/Thu, 01 Jan 2026 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/povala-ct-lanmit-2026/In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuumhttps://gbnegrinicv.netlify.app/publications/leffa-vivo-measured-2025/Sun, 14 Dec 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/leffa-vivo-measured-2025/CSF total tau as a proxy of synaptic degenerationhttps://gbnegrinicv.netlify.app/publications/soares-csf-2025/Fri, 29 Aug 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/soares-csf-2025/Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/abbas-utility-2025/Fri, 01 Aug 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/abbas-utility-2025/Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/rohden-glial-2025/Tue, 01 Jul 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/rohden-glial-2025/Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's diseasehttps://gbnegrinicv.netlify.app/publications/bellaver-plasma-2025/Thu, 01 May 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/bellaver-plasma-2025/Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegenerationhttps://gbnegrinicv.netlify.app/publications/povala-amyloid-2025/Wed, 01 Jan 2025 00:00:00 +0000https://gbnegrinicv.netlify.app/publications/povala-amyloid-2025/